Anti-Influenza A Virus Hemagglutinin H1 antibody (ab91531)
Key features and details
- Rabbit polyclonal to Influenza A Virus Hemagglutinin H1
- Suitable for: ELISA, WB
- Reacts with: Influenza A
- Isotype: IgG
Get better batch-to-batch reproducibility with a recombinant antibody
- Research with confidence – consistent and reproducible results with every batch
- Long-term and scalable supply – powered by recombinant technology for fast production
- Success from the first experiment – confirmed specificity through extensive validation
- Ethical standards compliant – production is animal-free
Overview
-
Product name
Anti-Influenza A Virus Hemagglutinin H1 antibody -
Description
Rabbit polyclonal to Influenza A Virus Hemagglutinin H1 -
Host species
Rabbit -
Specificity
ab91531 is specific for the seasonal Influenza A Virus Hemagglutinin H1 and does not cross-react with Swine Influenza A (H1N1) Hemagglutinin. -
Tested applications
Suitable for: ELISA, WBmore details -
Species reactivity
Reacts with: Influenza A -
Immunogen
A synthetic peptide from Influenza A Virus Hemagglutinin H1 (Genbank ACA28844).
-
Positive control
- Influenza A Virus Hemagglutinin H1
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
pH: 7.2
Preservative: 0.02% Sodium azide
Constituent: PBS -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Purification notes
Affinity chromatography purified via peptide column. -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab91531 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ELISA | ||
WB |
Notes |
---|
WB: Use at a concentration of 2 µg/ml. Predicted molecular weight: 63 kDa.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Target
-
Relevance
Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. In natural infection, inactive HA is matured into HA1 and HA2 outside the cell by one or more trypsin-like, arginine-specific endoprotease secreted by the bronchial epithelial cells. -
Database links
- Entrez Gene: 956529 Influenza A
- SwissProt: P03452 Influenza A
-
Alternative names
- HA antibody
- Hemagglutinin antibody
- Hemagglutinin HA antibody
Images
Datasheets and documents
-
SDS download
-
Datasheet download
References (4)
ab91531 has been referenced in 4 publications.
- Hajra D et al. Attenuation Methods for Live Vaccines. Methods Mol Biol 2183:331-356 (2021). PubMed: 32959252
- Wang X et al. Influenza A Virus Induces Autophagy by Its Hemagglutinin Binding to Cell Surface Heat Shock Protein 90AA1. Front Microbiol 11:566348 (2020). PubMed: 33117314
- Fan RL et al. Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias. J Virol 89:10762-73 (2015). WB . PubMed: 26269186
- Price JV et al. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS One 8:e64555 (2013). PubMed: 23734205